Electroanatomic mapping with CARTO requires point-by-point acquisition using the mapping catheter's bipolar tip electrode. This study evaluates the utility of a novel 26-electrode catheter (Qwikstar) for electroanatomic mapping of arrhythmias in patients with structural heart disease. The multielectrode catheter acquires activation times and anatomic data simultaneously from its tip and shaft electrodes. Eight patients (6 men, 2 women, age 47 years [37, 65]) with atrial tachycardia (n = 6) and ventricular tachycardia (n = 2) due to congenital heart disease (n = 4) and cardiomyopathy (n = 4) were studied. Using the multielectrode catheter, the electroanatomic map was constructed in two stages: (1) a scout map using the minimum number of tip and shaft electrode data points that covered > 70% of the tachycardia cycle length and/or the majority of the chamber volume, and (2) a complete map using additional tip electrode data points. A total of 36 (28, 510) tip electrode and 38 (34, 42) shaft electrode electroanatomic data points comprised the scout map. The complete map was constructed with a total of 102 (73, 134) tip electrode electroanatomic data points. In three patients, the scout map suggested a cavotricuspid isthmus dependent atrial flutter that was confirmed with the complete map. In another four patients, the scout map identified the earliest site of focal activation, which was also confirmed with the complete map. In comparison, activation mapping using the bipolar catheter (Navistar) in a group of arrhythmia-matched control subjects required 210 (180, 320) electroanatomic data points (P = 0.012 vs multielectrode catheter complete map). In conclusion, for large macroreentrant or focal arrhythmias in patients with structural heart disease, the multielectrode catheter can generate a scout map that accurately guides complete electroanatomic mapping using fewer point-by-point acquisitions than the bipolar catheter.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1540-8159.2004.00587.x | DOI Listing |
Heart Rhythm
January 2025
Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel - Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.
Background: Catheter ablation is an effective treatment for atrial fibrillation (AF). Pulsed field ablation (PFA) has emerged as a novel energy modality, which relies on high-voltage electric fields to achieve cardiac tissue ablation. Data on its efficacy in the elderly are scarce.
View Article and Find Full Text PDFJACC Clin Electrophysiol
January 2025
Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, New South Wales, Australia. Electronic address:
Background: Accurate electroanatomic mapping is critical for identifying scar and the long-term success of ventricular tachycardia ablation.
Objectives: This study sought to determine the accuracy of multielectrode mapping (MEM) catheters to identify scar on cardiac magnetic resonance (CMR) and histopathology.
Methods: In an ovine model of myocardial infarction, we examined the effect of electrode size, spacing, and mapping rhythm on scar identification compared to CMR and histopathology using 5 multielectrode mapping catheters.
Introduction: Pulsed-field ablation (PFA) is a novel modality for pulmonary vein isolation in patients with atrial fibrillation (AF). We describe the initial uptake and experience of PFA using a pentaspline catheter across selected National Health Service England (NHSE) centres.
Methods: Data collected by NHSE Specialised Services Development Programme regarding AF ablation procedures using a single-shot, pentaspline, multielectrode PFA catheter (FARAWAVE, Boston Scientific) between June 2022 and August 2024 were aggregated and analysed to examine procedural metrics, acute efficacy and safety outcomes over 3-month follow-up.
J Cardiovasc Electrophysiol
December 2024
Mercy General Hospital and Dignity Health Heart and Vascular Institute, Sacramento, California, USA.
Introduction: The safety and efficacy of paroxysmal atrial fibrillation (PAF) ablation with the HELIOSTAR multielectrode radiofrequency (RF) balloon catheter have been demonstrated in European studies; data from elsewhere are lacking. This prospective, multicenter study conducted in the United States, Italy, and China investigated the safety and efficacy of pulmonary vein isolation (PVI) using HELIOSTAR in drug-refractory symptomatic PAF.
Methods: The primary effectiveness endpoint (PEE) was 12-month freedom from documented atrial fibrillation/atrial flutter/atrial tachycardia plus freedom from acute procedural failure, nonstudy catheter failure, repeat ablation failure, direct current cardioversion (DCCV), and Class I/III antiarrhythmic drug (AAD) failure.
Sci Adv
December 2024
Laboratory of Flexible Electronics Technology, Tsinghua University, Beijing, 100084, China.
Atrial fibrillation leads to severe diseases such as heart failure and strokes. While catheter ablation is prevalent for the treatment, existing techniques hardly can achieve both tissue selectivity and ablation uniformity. Here, we propose a bioinspired strategy for balloon-based pulsed field ablation (PFA) systems based on "flounder" electrodes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!